Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 2
1982 2
1984 2
1986 2
1987 3
1988 3
1989 1
1990 5
1991 4
1992 5
1993 5
1994 9
1995 14
1996 13
1997 8
1998 9
1999 7
2000 12
2001 30
2002 14
2003 17
2004 31
2005 50
2006 51
2007 75
2008 60
2009 83
2010 115
2011 146
2012 171
2013 211
2014 213
2015 262
2016 247
2017 318
2018 318
2019 354
2020 521
2021 596
2022 713
2023 714
2024 137

Text availability

Article attribute

Article type

Publication date

Search Results

4,926 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer.
Li S, Yu W, Xie F, Luo H, Liu Z, Lv W, Shi D, Yu D, Gao P, Chen C, Wei M, Zhou W, Wang J, Zhao Z, Dai X, Xu Q, Zhang X, Huang M, Huang K, Wang J, Li J, Sheng L, Liu L. Li S, et al. Among authors: xie f. Nat Commun. 2023 Jan 3;14(1):8. doi: 10.1038/s41467-022-35431-x. Nat Commun. 2023. PMID: 36596787 Free PMC article. Clinical Trial.
Pityriasis Amiantacea.
Xie F, Sominidi-Damodaran S. Xie F, et al. Mayo Clin Proc. 2022 Oct;97(10):1769-1770. doi: 10.1016/j.mayocp.2022.06.010. Mayo Clin Proc. 2022. PMID: 36202489 No abstract available.
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study.
Harding JJ, Fan J, Oh DY, Choi HJ, Kim JW, Chang HM, Bao L, Sun HC, Macarulla T, Xie F, Metges JP, Ying J, Bridgewater J, Lee MA, Tejani MA, Chen EY, Kim DU, Wasan H, Ducreux M, Bao Y, Boyken L, Ma J, Garfin P, Pant S; HERIZON-BTC-01 study group. Harding JJ, et al. Among authors: xie f. Lancet Oncol. 2023 Jul;24(7):772-782. doi: 10.1016/S1470-2045(23)00242-5. Epub 2023 Jun 2. Lancet Oncol. 2023. PMID: 37276871 Clinical Trial.
Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trial.
Mao YP, Wang SX, Gao TS, Zhang N, Liang XY, Xie FY, Zhang Y, Zhou GQ, Guo R, Luo WJ, Li YJ, Liang SQ, Lin L, Li WF, Liu X, Xu C, Chen YP, Lv JW, Huang SH, Liu LZ, Li JB, Tang LL, Chen L, Sun Y, Ma J. Mao YP, et al. Among authors: xie fy. BMJ. 2023 Feb 6;380:e072133. doi: 10.1136/bmj-2022-072133. BMJ. 2023. PMID: 36746459 Free PMC article. Clinical Trial.
4,926 results